1. Home
  2. SPRB vs PNST Comparison

SPRB vs PNST Comparison

Compare SPRB & PNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • PNST
  • Stock Information
  • Founded
  • SPRB 2014
  • PNST 2007
  • Country
  • SPRB United States
  • PNST United States
  • Employees
  • SPRB N/A
  • PNST N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • PNST Blank Checks
  • Sector
  • SPRB Health Care
  • PNST Finance
  • Exchange
  • SPRB Nasdaq
  • PNST Nasdaq
  • Market Cap
  • SPRB 15.7M
  • PNST 18.1M
  • IPO Year
  • SPRB 2020
  • PNST N/A
  • Fundamental
  • Price
  • SPRB $0.42
  • PNST $0.32
  • Analyst Decision
  • SPRB Hold
  • PNST Strong Buy
  • Analyst Count
  • SPRB 7
  • PNST 3
  • Target Price
  • SPRB $2.17
  • PNST $2.50
  • AVG Volume (30 Days)
  • SPRB 417.1K
  • PNST 87.0K
  • Earning Date
  • SPRB 03-12-2025
  • PNST 02-19-2025
  • Dividend Yield
  • SPRB N/A
  • PNST N/A
  • EPS Growth
  • SPRB N/A
  • PNST N/A
  • EPS
  • SPRB N/A
  • PNST N/A
  • Revenue
  • SPRB $7,101,000.00
  • PNST $123,579,000.00
  • Revenue This Year
  • SPRB N/A
  • PNST $15.43
  • Revenue Next Year
  • SPRB N/A
  • PNST $17.79
  • P/E Ratio
  • SPRB N/A
  • PNST N/A
  • Revenue Growth
  • SPRB N/A
  • PNST 11.06
  • 52 Week Low
  • SPRB $0.34
  • PNST $0.31
  • 52 Week High
  • SPRB $5.95
  • PNST $4.26
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 58.94
  • PNST 39.45
  • Support Level
  • SPRB $0.38
  • PNST $0.31
  • Resistance Level
  • SPRB $0.42
  • PNST $0.50
  • Average True Range (ATR)
  • SPRB 0.03
  • PNST 0.06
  • MACD
  • SPRB 0.00
  • PNST -0.00
  • Stochastic Oscillator
  • SPRB 69.77
  • PNST 5.56

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About PNST Pinstripes Holdings Inc.

Pinstripes Holdings Inc is an experiential dining and entertainment concept combining exceptional Italian-American cuisine with bowling, bocce, and private events. It owns and operates around 17 restaurants in the USA. The company designs and constructs large-format locations that are each 26,000 to 38,000 square feet of interior space, plus additional outdoor patio space that includes outdoor dining, bocce courts, fire-pits, and decorative fountains.

Share on Social Networks: